ClinActis support clients to select the best approach that Asia Pacific can offer for the development of their product, depending on the study phase and therapeutic area. Some countries are better suited for certain therapeutic area than others. For early phase clinical trials, only a limited number of locations are available in Asia. The ClinActis team will assess the best strategy to implement your clinical trials in the region, based on our extensive expertise and experience of the region.